Clinical Trial

Improving the Quality of Coronary Artery Bypass Grafting

Study acronym: CABG Quality
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a healthcare quality improvement study focused on increasing the utilization of arterial grafts in isolated coronary artery bypass grafting (CABG). Evidence indicates that arterial grafts, compared with venous grafts, provide superior long-term patency, which are recommended to use by the clinical practice guidelines. In hospitals where the use of the internal mammary artery as a graft is relatively low(\<90%) among CABG patients, multiple interventions will be implemented to improve its adoption rate. In hospitals where internal mammary artery graft utilization is already high(≥90%), various interventions will be introduced to promote the use of multiple arterial grafts (defined as the use of two or more arterial conduits). The study targets healthcare professionals as the primary subjects of intervention, with no direct interventions applied to patients during the study period. Changes in the internal mammary artery graft utilization rate and the multiple arterial graft utilization rate before and after the intervention will serve as the primary endpoints for evaluating intervention effectiveness in the two types of hospitals, respectively.
Trial Details
NCT Number NCT07377149
Lead Sponsor China National Center for Cardiovascular Diseases
Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital, Shandong Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, Guangdong Provincial People's Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, West China Hospital, First Affiliated Hospital of Wenzhou Medical University, Ruijin Hospital, The General Hospital of Northern Theater Command, Central China Fuwai Hospital of Zhengzhou University
Conditions Coronary Artery Bypass Grafting (CABG)
Enrollment 8,700 participants
Start Date 2026-03-15
Primary Completion 2029-01 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-29